Language Disorders
|
group |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Mental or Behavioral Dysfunction
|
94
|
25
|
0.030 |
None |
1.000 |
3 |
|
2009 |
2013 |
Serum HDL cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
283
|
679
|
0.100 |
None |
1.000 |
2 |
1
|
2010 |
2013 |
Idiopathic Nephrotic Syndrome
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
51
|
72
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Dyslexia
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders
|
Mental or Behavioral Dysfunction
|
118
|
30
|
0.020 |
None |
1.000 |
2 |
|
2011 |
2014 |
Adiponectin Measurement
|
phenotype |
|
Laboratory Procedure
|
25
|
70
|
0.100 |
None |
1.000 |
2 |
1
|
2012 |
2014 |
Nephroblastoma
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
586
|
125
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Specific language impairment
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
34
|
9
|
0.040 |
None |
1.000 |
4 |
|
2009 |
2017 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2017 |
Nephrotic Syndrome
|
group |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
384
|
45
|
0.020 |
None |
1.000 |
2 |
|
2010 |
2017 |
Diastolic blood pressure
|
phenotype |
|
Clinical Attribute
|
507
|
1037
|
0.100 |
None |
1.000 |
2 |
2
|
2017 |
2017 |
Developmental delay (disorder)
|
phenotype |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
584
|
68
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2017 |
Pervasive Development Disorder
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
328
|
49
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2017 |
Global developmental delay
|
disease |
|
Mental or Behavioral Dysfunction
|
1825
|
553
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2017 |
Autism Spectrum Disorders
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1071
|
331
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2017 |
Smoking Behaviors
|
phenotype |
Behavior and Behavior Mechanisms
|
Individual Behavior
|
249
|
742
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Smoking
|
phenotype |
Behavior and Behavior Mechanisms
|
Individual Behavior
|
391
|
765
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Small cell carcinoma of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
972
|
125
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Physical Activity Measurement
|
phenotype |
|
Laboratory Procedure
|
160
|
355
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Kidney Diseases
|
group |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
1180
|
140
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Leukemia, Myelocytic, Acute
|
disease |
Neoplasms
|
Neoplastic Process
|
3111
|
6892
|
0.100 |
None |
1.000 |
1 |
10
|
2017 |
2017 |
Angioimmunoblastic Lymphadenopathy
|
disease |
Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
109
|
8
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Glioma
|
disease |
Neoplasms
|
Neoplastic Process
|
3097
|
353
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Nephrotic Syndrome, Minimal Change
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
85
|
10
|
0.030 |
None |
1.000 |
3 |
|
2013 |
2018 |
Metastatic Prostate Carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
362
|
24
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Metastasis from malignant tumor of prostate
|
disease |
|
Neoplastic Process
|
342
|
18
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |